Skip to main content

Immunodeficiency Disorders

The immune system is easy to take for granted until part of it fails. When a specific arm — antibodies, T cells, phagocytes, or complement — is missing or broken, the pattern of infections that follows is often so characteristic that a sharp clinician can name the defective component before any test comes back. Immunodeficiency disorders are the natural experiments that first taught us what each part of the immune system actually does, and they remain a high-yield exam topic precisely because "the infection tells you the hole."

This page teaches you to think in patterns: which immune component protects against which class of organism, how to separate rare inborn (primary) defects from the far more common acquired (secondary) ones — HIV above all — and how the story of one boy who lived his whole life inside a plastic bubble reshaped both the science and the ethics of immunology.

Learning Objectives​

  • Distinguish primary (inherited) from secondary (acquired) immunodeficiency and give leading examples of each.
  • Map each immune component (B cell/antibody, T cell, phagocyte, complement) to its signature infection profile.
  • Describe SCID, its subtypes, and why it is a pediatric emergency, using the "bubble boy" history to anchor the concept.
  • Explain HIV pathophysiology, natural history, and the CD4-based definition of AIDS.
  • Recognise the "warning signs" that should prompt an immunodeficiency workup and outline first-line investigations.

Quick Answer​

Immunodeficiencies are disorders where part of the immune system fails, producing recurrent, severe, unusual, or opportunistic infections. Primary immunodeficiencies (PIDs) are inherited defects present from birth — over 450 are now recognised — ranging from mild (selective IgA deficiency) to fatal (severe combined immunodeficiency, SCID). Secondary immunodeficiencies are acquired and far more common, caused by HIV, chemotherapy, malnutrition, diabetes, corticosteroids, or splenectomy. The infecting organism points to the defect: antibody/complement problems cause encapsulated bacterial infections; T-cell problems cause viral, fungal, and opportunistic infections; phagocyte problems cause skin abscesses and catalase-positive organisms. SCID abolishes T-cell (and often B-cell and NK) function and kills infants within the first year unless treated with bone marrow transplant or gene therapy. HIV progressively destroys CD4 T cells; AIDS is diagnosed when CD4 falls below 200 cells/µL or an AIDS-defining illness appears.

Where It Came From​

For most of medical history, dying young of infection was simply "how things were," and no one could distinguish a child with a broken immune system from an unlucky child in a world before antibiotics. The concept of a specific, inherited immune defect required first understanding that the immune system had separable parts — and that only crystallised in the mid-20th century.

The turning point came in 1952, when US Army pediatrician Colonel Ogden Bruton used the newly available technique of serum protein electrophoresis on an eight-year-old boy who had suffered nineteen episodes of sepsis. The boy's serum was missing its gamma-globulin fraction entirely — he made essentially no antibodies. Bruton had described the first named primary immunodeficiency, X-linked (Bruton) agammaglobulinemia, and, crucially, he showed it could be treated by injecting gamma globulin. For the first time a specific immune defect had a name, a mechanism, and a therapy.

The 1950s and 60s then revealed that immunity was not one system but at least two arms. Work on chickens showed that removing the bursa of Fabricius wiped out antibodies while removing the thymus wiped out cell-mediated immunity and graft rejection — the origin of the terms "B cell" (bursa) and "T cell" (thymus). This division immediately explained why some children died of bacteria and others of viruses and fungi.

The most dramatic and defining disease was severe combined immunodeficiency (SCID), first described in the 1950s in Swiss infants (hence the old term "Swiss-type agammaglobulinemia"). These babies had no working T cells and no antibodies — no adaptive immunity at all — and died in infancy from infections that a normal child shrugs off. SCID became famous to the general public through David Vetter, the "bubble boy" of Houston, born in 1971. Knowing from a previous son's death that David likely had X-linked SCID, his physicians delivered him by caesarean straight into a sterile plastic isolator, hoping to keep him infection-free until a bone-marrow transplant became possible. No matched donor was found. David lived his entire life — nearly 13 years — inside sequential germ-free bubbles, a haunting demonstration of what life without a functioning immune system requires. In 1983 he received a bone-marrow transplant from his sister using a newer donor-matching technique; the marrow unknowingly carried latent Epstein-Barr virus, which, with no immune system to contain it, drove a fatal B-cell lymphoma. He died in 1984. His case propelled research funding, sharpened the ethics of extraordinary life-sustaining measures, and made "curing SCID" a defining goal — a goal now largely met by newborn screening, transplantation, and, for some subtypes, gene therapy.

Finally, in 1981, clusters of Pneumocystis pneumonia and Kaposi sarcoma in previously healthy young gay men in Los Angeles and New York announced a new, acquired, epidemic immunodeficiency. By 1983–84 the cause — human immunodeficiency virus (HIV) — was identified, and secondary immunodeficiency moved from a medical curiosity to a global catastrophe that has since killed over 40 million people.

Reading the Pattern: Which Defect Causes Which Infection​

The single most useful clinical skill in this topic is matching organism to defect. Each immune component defends against a characteristic class of pathogen, so the infections a patient keeps getting reveal the missing piece.

  • Antibody (B-cell) defects → recurrent encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria), sinopulmonary infections (otitis, sinusitis, pneumonia), and enteroviruses/Giardia. Antibodies opsonise capsules the innate system can't grip.
  • T-cell defects → viruses, fungi, and intracellular/opportunistic organisms: severe or persistent Candida, Pneumocystis jirovecii, cytomegalovirus, disseminated mycobacteria. Because T cells also help B cells, T-cell defects usually cause combined problems.
  • Phagocyte defects → recurrent skin and deep abscesses, poor wound healing, and catalase-positive organisms (Staphylococcus aureus, Serratia, Nocardia, Aspergillus) — the classic picture of chronic granulomatous disease.
  • Complement defects → recurrent Neisseria infections (meningococcus, gonococcus) with terminal-pathway (C5–C9) defects; early-component defects mimic antibody deficiency and cause lupus-like autoimmunity.

Primary Immunodeficiencies​

Primary immunodeficiencies are inherited, usually presenting in infancy or childhood, though milder forms surface in adulthood.

Selective IgA deficiency is the most common PID (roughly 1 in 500 people). Most are asymptomatic; some have recurrent sinopulmonary or GI infections and autoimmune disease. A practical exam point: these patients can develop anaphylaxis to blood products containing IgA because they may form anti-IgA antibodies.

Common variable immunodeficiency (CVID) is the most common symptomatic antibody deficiency, typically presenting in the 20s–30s with recurrent sinopulmonary infections, low IgG plus low IgA and/or IgM, and poor vaccine responses. It carries increased rates of autoimmunity, bronchiectasis, and lymphoma. Treatment is lifelong immunoglobulin replacement.

X-linked (Bruton) agammaglobulinemia results from a BTK gene mutation that arrests B-cell maturation, so affected boys have essentially no B cells and no immunoglobulins. Infections begin around 6 months, as maternal antibody wanes. Tonsils and lymph nodes are strikingly absent.

DiGeorge syndrome (22q11.2 deletion) is a T-cell defect from failed development of the third and fourth pharyngeal pouches, giving thymic hypoplasia (T-cell deficiency), hypocalcemia from absent parathyroids (tetany, seizures), cardiac outflow defects, and characteristic facies — memorised as CATCH-22: Cardiac, Abnormal facies, Thymic hypoplasia, Cleft palate, Hypocalcemia.

SCID: the immunologic emergency​

Severe combined immunodeficiency is the most severe PID: T cells are absent or non-functional, and B cells are absent or useless without T-cell help; some subtypes also lack NK cells. The commonest form is X-linked SCID from mutation in the common gamma chain (IL2RG), a shared component of several cytokine receptors — hence T⁻ B⁺ NK⁻. Adenosine deaminase (ADA) deficiency is a major autosomal-recessive form: toxic metabolites accumulate and kill lymphocytes, giving T⁻ B⁻ NK⁻.

Infants present in the first months with failure to thrive, chronic diarrhea, persistent oral thrush, and severe infections — often Pneumocystis pneumonia. Two danger points: never give a live vaccine (BCG, rotavirus, oral polio) to a SCID infant — it can disseminate and kill — and always irradiate blood products to prevent transfusion-associated graft-versus-host disease. Many countries now perform newborn SCID screening by measuring TRECs (T-cell receptor excision circles), a DNA marker of new thymic T cells that is low or absent in SCID. Early detection matters enormously: hematopoietic stem cell transplant before three months of age, ideally before infection sets in, achieves survival above 90%. Gene therapy has cured ADA-SCID and is used for X-linked SCID.

Secondary Immunodeficiencies​

Acquired immunodeficiencies are vastly more common than primary ones. Causes include HIV, malnutrition (the leading global cause), cancers (especially leukemia/lymphoma and multiple myeloma), chemotherapy and immunosuppressants, corticosteroids, diabetes, chronic kidney or liver disease, and splenectomy (which removes a key filter for encapsulated organisms — asplenic patients need pneumococcal, meningococcal, and Hib vaccination and often prophylactic penicillin).

HIV and AIDS​

HIV is a retrovirus that infects cells bearing CD4 — chiefly helper T cells, plus macrophages and dendritic cells — using CD4 plus a co-receptor (CCR5 or CXCR4) to enter. Its enzyme reverse transcriptase copies viral RNA into DNA, which integrase splices into the host genome, establishing a lifelong reservoir. Because helper CD4 T cells orchestrate nearly the entire adaptive response, their progressive loss collapses immunity from the top down.

Natural history runs in three phases: an acute retroviral syndrome (a mononucleosis-like fever, rash, and lymphadenopathy weeks after exposure, with very high viral load), a clinical latency of years during which CD4 counts slowly fall, and finally AIDS. In an adult, AIDS is defined by a CD4 count below 200 cells/µL or the presence of an AIDS-defining illness, regardless of count.

The CD4 count predicts which opportunistic infections appear — another organism-to-count pattern worth memorising:

CD4 count (cells/µL)Characteristic opportunistic illnesses
Below 200Pneumocystis jirovecii pneumonia (PCP)
Below 100Cerebral toxoplasmosis; cryptococcal meningitis
Below 50Cytomegalovirus retinitis; disseminated Mycobacterium avium complex (MAC)

Diagnosis uses a 4th-generation antigen/antibody test (detects p24 antigen plus antibody), confirmed and monitored by viral load (HIV RNA PCR), with CD4 count gauging immune status. Treatment is antiretroviral therapy (ART) — combinations that block reverse transcriptase, protease, or integrase. Modern ART suppresses viral load to undetectable, restores CD4 counts, prevents AIDS, and renders patients non-infectious sexually (U=U, undetectable equals untransmittable). Prophylaxis (e.g. co-trimoxazole for PCP when CD4 is below 200) protects until immunity recovers.

Real-World Applications​

  • Newborn screening: TREC-based SCID screening on the heel-prick card now catches affected babies before infection, converting a near-uniformly fatal disease into a curable one — a triumph directly descended from David Vetter's story.
  • Vaccination strategy: Knowing a patient is asplenic, on high-dose steroids, or has an antibody deficiency changes practice immediately — give the extra vaccines they need, and withhold live vaccines from the severely T-cell deficient.
  • Public health: ART as prevention (treatment-as-prevention and PrEP) has turned HIV from a death sentence into a manageable chronic condition and a controllable epidemic.
  • Recognising the adult "zebra": The 30-year-old with recurrent pneumonia, bronchiectasis, and low IgG is not just unlucky — checking immunoglobulins can diagnose CVID and prevent years of lung damage.

Common Mistakes​

  1. Thinking recurrent infection always means immunodeficiency. Most children with frequent colds are normal. True red flags are infections that are recurrent AND severe, unusual, opportunistic, poorly responsive to treatment, or in multiple sites — plus failure to thrive or a family history. Anatomic or foreign-body causes (a single recurrent site) are far more common than PID.

  2. Giving live vaccines or non-irradiated blood to a SCID infant. This is a lethal error. Live vaccines can disseminate, and viable donor lymphocytes in blood cause fatal graft-versus-host disease. Any infant with suspected severe T-cell defect gets only irradiated, CMV-safe blood and no live vaccines.

  3. Equating HIV infection with AIDS. HIV-positive is not the same as having AIDS. AIDS is the late stage defined by CD4 below 200 or an AIDS-defining illness. On effective ART, a person can be HIV-positive for life and never develop AIDS.

  4. Forgetting complement in recurrent Neisseria. A patient with a second episode of meningococcal disease should trigger a terminal complement (CH50) workup, not just reassurance.

Comparison and Connections​

FeaturePrimary immunodeficiencySecondary immunodeficiency
CauseInherited genetic defectAcquired (HIV, drugs, malnutrition, cancer)
OnsetUsually infancy/childhoodAny age, follows the insult
FrequencyRare individuallyCommon
ExampleSCID, CVID, CGDHIV/AIDS, chemotherapy, splenectomy
ReversibilityFixed (may be cured by transplant/gene therapy)Often reversible if cause is removed

The organism-to-defect logic connects this topic to microbiology (encapsulated organisms, opportunists) and to pharmacology (immunosuppressants and antiretrovirals). The developmental defects of DiGeorge link to embryology of the pharyngeal pouches, and HIV epidemiology sits within community medicine.

Practice Questions​

Recall​

Q: What is the classic infection profile of a complement terminal-pathway (C5–C9) deficiency? A: Recurrent Neisseria infections (meningococcal and gonococcal disease).

Understanding​

Q: Why do antibody deficiencies typically present around 6 months of age rather than at birth? A: Maternal IgG crosses the placenta and protects the infant for the first months of life. Symptoms emerge as this passively transferred antibody wanes and the infant's own (absent) antibody production is needed.

Application​

Q: A 3-month-old has failure to thrive, oral thrush, chronic diarrhea, and Pneumocystis pneumonia. Absent thymic shadow on chest film. What must you avoid, and what is the definitive treatment? A: Suspect SCID. Avoid live vaccines and give only irradiated, CMV-safe blood products. Definitive treatment is hematopoietic stem cell transplant (ideally before 3 months and before infection); gene therapy for certain subtypes such as ADA-SCID.

Analysis​

Q: An HIV-positive man presents with a headache and a CD4 count of 80. Why is the CD4 count central to your differential, and what two CNS infections top your list? A: The CD4 count predicts which opportunists can occur. Below 100, cerebral toxoplasmosis and cryptococcal meningitis become likely, so both head the differential (imaging for ring-enhancing lesions; CSF cryptococcal antigen).

FAQ​

Is selective IgA deficiency dangerous? Usually not — most people never know they have it. The main risks are recurrent mild sinopulmonary/GI infections, associated autoimmune disease, and rare anaphylactic reactions to IgA-containing blood products.

Can primary immunodeficiencies be cured? Some can. SCID and several other severe combined or phagocyte defects are curable with hematopoietic stem cell transplant, and gene therapy has cured ADA-SCID. Antibody deficiencies like CVID aren't cured but are well controlled with lifelong immunoglobulin replacement.

Why did the "bubble boy" die if he was transplanted? The donor marrow carried latent Epstein-Barr virus. With no functioning immune system to hold EBV in check, the virus drove an aggressive B-cell lymphoma. His death spurred research into EBV, transplantation, and donor screening.

What is the difference between HIV and AIDS? HIV is the virus and the state of being infected. AIDS is the advanced stage of untreated HIV, defined by a CD4 count below 200 cells/µL or an AIDS-defining illness. With effective ART, HIV rarely progresses to AIDS.

What are the "warning signs" that should prompt an immunodeficiency workup? Recurrent severe infections, infections needing IV antibiotics or that fail to clear, two or more pneumonias or serious sinus infections in a year, deep abscesses, persistent thrush after age one, failure to thrive, opportunistic infections, and a family history of early infant death or known immunodeficiency.

Quick Revision​

  • Primary = inherited (rare); secondary = acquired (common; HIV, malnutrition, drugs, splenectomy).
  • The organism reveals the defect: antibody/complement → encapsulated bacteria & Neisseria; T cell → viruses/fungi/opportunists; phagocyte → abscesses & catalase-positive organisms.
  • Bruton (1952) described the first PID (X-linked agammaglobulinemia); "B" from bursa, "T" from thymus.
  • SCID = no adaptive immunity; commonest form X-linked (IL2RG); ADA deficiency is a key AR form. Emergency: transplant before 3 months, no live vaccines, irradiated blood. Screen with TRECs.
  • David Vetter (bubble boy) died 1984 of EBV-driven lymphoma after transplant.
  • HIV kills CD4 T cells; AIDS = CD4 below 200 or AIDS-defining illness. CD4 below 200 → PCP; below 100 → toxo/crypto; below 50 → CMV/MAC. Treat with ART; U=U.

Prerequisites​

  • Immunology branch overview: ../index.md
  • Cells and organs of the immune system; innate vs adaptive immunity

Next Topics​